TrialJournal of neuro-oncology2016
A phase II trial evaluating the effects and intra-tumoral penetration of bortezomib in patients with recurrent malignant gliomas.
Jeffrey J Raizer et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this papercites it